Literature DB >> 35764389

An Update on the Biologic Effects of Fenbendazole.

Carolyn Cray1, Norman H Altman2.   

Abstract

Fenbendazole remains the drug of choice to treat pinworm infection in laboratory rodents. When fenbendazole was last reviewed (15 y ago), the literature supported the drug's lack of toxic effects at therapeutic levels, yet various demonstrated physiologic effects have the potential to alter research outcomes. Although more recent reports continue to reflect an overall discordancy of results, several studies support the premise that fenbendazole affects the bone marrow and the immune system. No effects on reproduction were reported in an extensive study that assessed common treatment protocols in mice, and food intake was unchanged in rats. Behavioral studies are sparse, with only a single report of a subtle change in a rotarod performance in mice. Notably, unexpected results in tumor models during facility treatment with fenbendazole have prompted preclinical and clinical studies of the potential roles of benzimidazoles in cancer.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35764389      PMCID: PMC9413524          DOI: 10.30802/AALAS-CM-22-000006

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   1.565


  53 in total

1.  Hematopoietic changes and altered reactivity to IL-17 in Syphacia obvelata-infected mice.

Authors:  Diana Bugarski; Gordana Jovcić; Sofija Katić-Radivojević; Marijana Petakov; Aleksandra Krstić; Nevenka Stojanović; Pavle Milenković
Journal:  Parasitol Int       Date:  2005-12-01       Impact factor: 2.230

2.  Prophylactic fenbendazole therapy does not affect the incidence and onset of type 1 diabetes in non-obese diabetic mice.

Authors:  Deanna D H Franke; Haval Shirwan
Journal:  Int Immunol       Date:  2006-01-13       Impact factor: 4.823

3.  Efficacy and safety of topical selamectin to eradicate pinworm (Syphacia spp.) infections in rats (Rattus norvegicus) and mice (Mus musculus).

Authors:  William Allen Hill; Mildred Montgomery Randolph; Sharon Jean Lokey; Ernestine Hayes; Kelli Lynn Boyd; Timothy David Mandrell
Journal:  J Am Assoc Lab Anim Sci       Date:  2006-05       Impact factor: 1.232

4.  Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer.

Authors:  Tara Williamson; Thais Biude Mendes; Natalie Joe; Janete M Cerutti; Gregory J Riggins
Journal:  Endocr Relat Cancer       Date:  2020-03       Impact factor: 5.678

5.  Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma.

Authors:  Christine G Skibinski; Tara Williamson; Gregory J Riggins
Journal:  J Neurooncol       Date:  2018-11-09       Impact factor: 4.130

6.  The lack of behavioral effects of fenbendazole: a medication for pinworm infection.

Authors:  Richard Keen; Mika Macinnis; Paulo Guilhardi; Karen Chamberland; Russell Church
Journal:  Contemp Top Lab Anim Sci       Date:  2005-03

7.  The behavioral teratogenic potential of fenbendazole: a medication for pinworm infestation.

Authors:  S Barron; B J Baseheart; T M Segar; T Deveraux; J A Willford
Journal:  Neurotoxicol Teratol       Date:  2000 Nov-Dec       Impact factor: 3.763

8.  Effects of Maternal Fenbendazole on Litter Size, Survival Rate, and Weaning Weight in C57BL/6J Mice.

Authors:  Kristina L Hicks; Elysia Roche; James D Wilkerson; Krista E Lindstrom
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-11-09       Impact factor: 1.232

9.  Treatment of mice with fenbendazole attenuates allergic airways inflammation and Th2 cytokine production in a model of asthma.

Authors:  Yeping Cai; Jiansheng Zhou; Dianne C Webb
Journal:  Immunol Cell Biol       Date:  2009-07-21       Impact factor: 5.126

10.  Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information.

Authors:  Teppei Yamaguchi; Junichi Shimizu; Yuko Oya; Yoshitsugu Horio; Toyoaki Hida
Journal:  Case Rep Oncol       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.